deltatrials
Completed PHASE3 NCT00000509

Potassium and Sodium to Control Blood Pressure in Hypertensives

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Cardiovascular Diseases Heart Diseases Hypertension Vascular Diseases
Interventions diet, potassium-supplementation diet, sodium-restricted
Updated 7 times since 2017 Last updated: Mar 14, 2017 Started: Sep 30, 1983 Primary completion: Sep 30, 2003 Completion: Sep 30, 2003

Listed as NCT00000509, this PHASE3 trial focuses on Cardiovascular Diseases and Heart Diseases and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 7 times since 1983, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Nov 2019 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jun 2018 — Nov 2019 [monthly]

    Completed PHASE3

▶ Show 2 earlier versions

  1. Apr 2017 — Jun 2018 [monthly]

    Completed PHASE3

  2. Jan 2017 — Apr 2017 [monthly]

    Completed PHASE3

    First recorded

Sep 1983

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
  • University of Minnesota
Data source: University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.